RE:RE:RE:RE:US tradingiscfa,
The 2016 PP was a flop?
Sorry, it was not a flop for Ceapro, it may have been a flop for you due to your paying too much for your shares. There is still one Cdn institutional investor left out of 4...................but you already knew that because you do your homework, right?
Ceapro has made very good use of the funds that came from that placement, they leveraged those funds to be able to do many things that have ultimately allowed them to grow the base business and create substantial cash flow. The company is in the best financial condition ever, it has no debt. So, was the PP a flop? Only in your mind because that is what you want to see happen with Ceapro.
It is odd that after 4.5 years you are still stuck in 2016, maybe you are the one who paid $2.47 for your shares in 2016?
Let me provide you with this. Back in 1997, there was a company called Vexco that Ceapro took over in order to go public. When the stock began to trade after the combination of the companies, I was the first person to buy shares in the amalgamated company at $5 5/8, trading was in fractions back then. The high for the stock the same day was $5 7/8.
Needless to say, I am still here and can tell that at $.70, I am doing very well but only because I have beleived in the company enough to continue to buy the stock at very low prices. It has been a long and winding road but so far, patience has paid off and I will continue to let things unfold.
Probably the most important item that comes out of this after all of these years is that the company has only 77.7 million outstanding shares. Considering what has transpired with the company and how close they have come on a few occasions to going under, this is an amazing accomplishment to say the least.
It is the two longest serving board members and past board members that refused to allow any form of unecessary dilution. They steadfastly refused to allow dilutive financings to take place. After 23 years of being a publicly traded company and only haveing 77.7 million O/S shares tells you a lot about the mindset of those who have been on the BOD. They may not have been Biotech allstars but they have all had good business sense.
Lastly, many are unaware of the fact that when the company was in dispair and needed short term funding or equipment to be purchased in earlier days, it was the BOD who stepped in to make things happen. Yes, they wrote cheques when the company needed them to do so.
It is important to take a step back and look at where the company has been and where it is planning to go. It is never a straight line, there are always pitfalls, obstacles and some disasters. What is important is where the company is today, not where it was in 2016 or 1997. If you are still stuck back in 2016, you will never realize the opportunity.